{[ promptMessage ]}

Bookmark it

{[ promptMessage ]}

Lecture_16

31 fig 82 approaches to anti hiv therapy fusion

Info iconThis preview shows pages 31–41. Sign up to view the full content.

View Full Document Right Arrow Icon
31 Fig 8.2 Approaches to anti-HIV therapy Fusion Inhibitors Integrase Inhibitors Protease Inhibitors Reverse Transcriptase Inhibitors
Background image of page 31

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full Document Right Arrow Icon
32 The History of AZT For many viral diseases therapeutic drugs are the exception rather than the rule Viral diseases effectively prevented by vaccination In 1964, AZT was initially developed as anti-cancer drug = not effective so shelved for 20 years In 1984, Mitsuya and Broder obtained a sample of HIV from Gallo and began testing > 300 drugs Inhibition of HIV infection of human T cell cultures AZT was potent inhibitor at conc. of minimal toxicity to human cells
Background image of page 32
33 Reverse Transcriptase Inhibitors (RTI) (A) Reverse Transcriptase (B) Inactive Reverse Transcriptase (C) Mutated Reverse Transcriptase Active site RTI in active site RTI does not fit in active site
Background image of page 33

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full Document Right Arrow Icon
34 How drug resistance emerges in an HIV population
Background image of page 34
35 Nucleoside Analogues Thymidine Azidothymidine Azido- group
Background image of page 35

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full Document Right Arrow Icon
36 Properties of AZT that make it a good inhibitor • Binds RT irreversibly = RT is non-functional • Permeable to cells / bind PO 4 gp at 5’ position • Has higher afFnity for RT than host cell polymerases • Stability • Administered orally
Background image of page 36
37 Figure 08.T03: Benefits and Obstacles to Use of AZT
Background image of page 37

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full Document Right Arrow Icon
38 Action of Reverse Transcriptase Inhibitors (A) Nucleoside Analogue (B) Non-Nucleoside Analogue Nucleoside Analogue is a DNA chain terminator Newly formed HIV DNA Inactivated Reverse Transcriptase Inhibitor
Background image of page 38
39 Protease Inhibitors A. Why HIV Protease is essential for HIV Replication B. How HIV Protease Inhibitors inhibit viral protease function Active/cutting site of enzyme
Background image of page 39

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full Document Right Arrow Icon
40 Protease Paunch
Background image of page 40
41 Buffalo Hump
Background image of page 41
This is the end of the preview. Sign up to access the rest of the document.

{[ snackBarMessage ]}

Page31 / 41

31 Fig 82 Approaches to anti HIV therapy Fusion Inhibitors...

This preview shows document pages 31 - 41. Sign up to view the full document.

View Full Document Right Arrow Icon bookmark
Ask a homework question - tutors are online